Harm Reduction International released a report, Harm reduction investment in the European Union: Current spending, challenges and successes ahead of the 25th Harm Reduction International Conference (HR17) taking place on 14 – 17 May 2017 in Montréal, Canada. [gview file="http://ecuo.org/mvdev/wp-content/uploads/sites/4/2017/05/HRWreportApril2017_web_1.pdf"] [gview file="http://ecuo.org/mvdev/wp-content/uploads/sites/4/2017/05/thepolicy2017_online_version.pdf"] Europe is the birthplace of harm ...

The European Medicines Agency’s (EMA) 2016 annual report published today focuses on the Agency’s key achievements in the areas of medicine evaluation, support to research and development of new and innovative treatments and the safety monitoring of medicines in real life. In 2016, the Agency recommended ...

Recurrent TB and associated factors: A five-year countrywide study in Uzbekistan Abstract Background In Uzbekistan, despite stable and relatively high tuberculosis treatment success rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent tuberculosis is when a patient who was treated for pulmonary tuberculosis and cured, ...